Abstract
Communications to improve intention to receive HPV vaccine
Highlights
For more than a decade, public health practitioners and researchers have been asking how uptake of a safe and effective anticancer vaccine can be improved
The most common reasons cited for lack of intention to vaccinate have become almost ubiquitous in reports of human papillomavirus (HPV) vaccine hesitance—safety concerns, vaccine not recommended, perception that the vaccine is not needed, and a lack of knowledge about the vaccine
Safety concerns were the most common barrier to intention to vaccinate when a recommendation was received from a health-care provider and the second most common was the perception that the vaccine was not needed
Summary
For more than a decade, public health practitioners and researchers have been asking how uptake of a safe and effective anticancer vaccine can be improved. In this issue of The Lancet Public Health, Kalyani Sonawane and colleagues[1] report on barriers to intention to start the human papillomavirus (HPV) vaccine series among US parents of unvaccinated adolescents, as well as barriers to intention to complete the series for those who started it.
Sign-in/Register to view highlights & summary Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
